Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai
Reexamination Certificate
1999-12-08
2001-11-20
Moezie, Minna (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heavy metal containing doai
Reexamination Certificate
active
06319947
ABSTRACT:
FIELD OF THE INVENTION
This invention relates to metallocene compositions containing vanadium (IV). More particularly, the invention relates to Vanadium (IV) complexed metallocene, having spermicidal activity.
BACKGROUND OF THE INVENTION
The known spermicidal agents, nonoxynol-9 and gramicidin, exert their effects via a detergent-like ability to damage the sperm plasma membrane, perturb its conformation and destroy its semi-permeable nature thereby impairing the sperm motility and egg fertilizing functions (Wilborn, et al.,
Fertil Steril
1983; 39:717-719; Bourinbaiar, et al.,
Life Sci
1994; 54:PL 5-9). Because of their non-specific membrane disruptive properties, such vaginal spermicides have been shown to damage the cervicovaginal epithelium, as well, which may lead to a lower degree of protection from sexually transmitted diseases (Niruthisard, et al.,
Sex Transm Dis
1991; 18:176-179). A novel vaginal contraceptive preferably does not function with the non-specific membrane toxicity mediated by detergent-type action of the currently available vaginal contraceptives.
Vanadium is a physiologically essential element which can be found in one of five (I to V) oxidation states. Several inorganic salts containing vanadium with oxidation state +4 (IV) have been shown to function as modulators of cellular redox potential and to exert pleiotropic effects in multiple biological systems by catalyzing the generation of reactive oxygen intermediates. See, for example, Shi, et al.,
Ann Clin Lab Sci
1996; 26:390-49; Byczkowski, et al.,
Bull Environ Contam Toxicol
1988; 41:696-703; Younes, et al.,
Toxicology
1991; 66:63-74, and Sakurai, et al.,
Biochem Biophys Res Commun
1995; 206:133-137. Reactive oxygen intermediates have been reported to affect sperm motility by a combination of peroxidation of membrane lipids and proteins (Aitken, et al.,
Biol Reprod
1989; 40:183-197; Jones, et al.,
Fertil Steril
1979; 31:531-537). Peroxidative damage to the sperm plasma membrane is an important pathophysiological mechanism in the onset of male infertility (Aitken, et al.,
BioEssays
1994; 16:259-267). It has also been shown that superoxide radicals generated by the action of xanthine oxidase exert a direct, suppressive effect on many aspects of sperm function (Aitken, et al.,
J. Reprod Fertil
. 1993; 97:441-450). Sperm are thought to be particularly susceptible to oxidative stress by virtue of their high content of unsaturated fatty acids and their relative paucity of cytoplasmic enzymes for scavenging the reactive oxygen intermediates that initiate lipid peroxidation (Alvarez, et al.,
J Androl
1987; 8:338-348).
There is a need for new spermicidal compounds for contraceptive purposes. The ability of vanadium IV containing organometallic complexes to catalyze the generation of reactive oxygen species was evaluated for its potential to impact sperm activity. Results of studies with structurally distinct organometallic complexes containing vanadium (IV) surprisingly demonstrated these compounds to be potent spermicidal agents at nano-micromolar concentrations. These compounds have also surprisingly been found to exhibit selective apoptosis-inducing activity against testicular germ cells in vivo.
SUMMARY OF THE INVENTION
Organometallic complexes containing vanadium (IV), including vanadocene dichloride (VDC), bis (methylcyclopentadienyl) vanadium dichloride (VMDC), vanadocene dibromide (VDB), vanadocene diiodide (VDI), vanadocene diazide (VDA), vanadocene dicyanide (VDCN), vanadocene dioxycyanate (VDOCN), vanadocene dithiocyanate (VDSCN), vanadocene diselenocyanate (VDSeCN), vanadocene ditriflate (VDT), vanadocene monochloro oxycyanate (VDCO), and vanadocene monochloro acetonitrilo tetrachloro ferrate (VDFE) were found to have spermicidal activity. Specifically, the “vanadocene” complexes elicited potent spermicidal activity at nano-micromolar concentrations with an order of efficacy VDSeCN>VDSCN>VDB>VMDC>VDA>VDC>VDI>VDT>VDFE>VDCO. In contrast, control metallocene complexes containing titanium, zirconium, molybdenum, and hafnium lacked spermicidal activity.
Accordingly, the present invention includes a contraceptive composition containing a spermicidal effective amount of an organometallic cyclopentadienyl vanadium IV complex and a pharmaceutically acceptable carrier, diluent or vehicle.
Another aspect of the present invention is a method of contraception including the step of contacting sperm with a spermicidal effective amount of an organometallic cyclopentadienyl vanadium IV complex.
Yet another embodiment of the invention utilizes the selective apoptotic-inducing properties of organometallic cyclopentadienyl vanadium IV complexes against testicular germ cells to selectively kill normal testicular germ cells and testicular germ cell tumors.
REFERENCES:
patent: 4297341 (1981-10-01), Waller et al.
patent: 4322399 (1982-03-01), Ahmad et al.
patent: 4368186 (1983-01-01), Vickery et al.
patent: 4432967 (1984-02-01), Szymanski
patent: 4559157 (1985-12-01), Smith et al.
patent: 4588581 (1986-05-01), Schmolka
patent: 4608387 (1986-08-01), Kopf et al.
patent: 4608392 (1986-08-01), Jacquet et al.
patent: 4613497 (1986-09-01), Chavkin
patent: 4707362 (1987-11-01), Nuwayser
patent: 4795425 (1989-01-01), Pugh
patent: 4820508 (1989-04-01), Wortzman
patent: 4917901 (1990-04-01), Bourbon et al.
patent: 4938949 (1990-07-01), Borch et al.
patent: 4992478 (1991-02-01), Geria
patent: 4999342 (1991-03-01), Ahmad et al.
patent: 5013544 (1991-05-01), Chantler et al.
patent: 5021595 (1991-06-01), Datta
patent: 5069906 (1991-12-01), Cohen et al.
patent: 5387611 (1995-02-01), Rubinstein
patent: 5407919 (1995-04-01), Brode et al.
patent: 5512289 (1996-04-01), Tseng et al.
patent: 5595980 (1997-01-01), Brode et al.
patent: 6051603 (2000-04-01), D'Cruz et al.
patent: 293 495 A5 (1991-09-01), None
patent: 0 407 804 A1 (1990-06-01), None
patent: WO 97/47296 (1997-12-01), None
Aistars, A. et al., 1997,Organometallics,vol. 16, pp. 1994-1996 “Convenient Synthesis of Dichloro(oxo)(pentamelthylcyclopentadienyl)vanadium(V), (&eegr;-C5M&egr;5)V(O)C12”.
Albini, A. et al., 1987Cancer Research,vol. 47, pp. 3239-3245 (Jun. 15, 1987) “A Rapid in Vitro Assay for Quantitating the Invasive Potential of Tumor Cells”.
Aubrecht, J. et al., 1999,Toxicology and Applied Pharmacology,vol. 154, No. 3, pp. 228-235 (Feb. 1, 1999) “Molecular Genotoxicity Profiles of Apoptosis-Inducing Vanadocene Complexes”.
Casey, A.T. et al., 1974,Aust. J. Chem,vol. 27, pp. 757-768 “Dithiochelates of the Bis(&eegr;-cyclopentadienyl)vanadium(IV) Moiety. II N,N-Dialkyldithiocarbamate and O,O′-Dialkyldithiophosphate Complexes”.
Chen, D. et al., 1992,Bopuxue Zazhi,vol. 9 No. 1, pp. 25-44 “ESR studies on the oxovanadium phenanthroline complexes” (Abstract only).
Chen, D. et al., 1993,Yingyong Huaxue,vol. 10, No. 3, pp. 66-71 “ESR Spectroscopic Study of Oxovanadium Complexes with His and &pgr;-Acceptor Ligands”.
Chen, D. et al., 1993,Chinese Journal of Magnetic Resonance,vol. 10, No. 3, pp. 287-294 (Sep. 1993) “Structure and ESR spectra of oxovanadium temary complexes with aspartic acid and pi.-acceptor ligands”.
Chen, D. et al., 1995,Chines Journal of Applied Chemistry,vol. 12, No. 2, pp. 59-62 (Apr. 1995) “Study on Structures and Spectra of Oxovanadium Complexes with Glu and Phen Ligands”.
Chen, D. et al., 1999,Journal of Magnetic Resonance,vol. 16, No. 1, pp. 53-58 (Feb. 1999) “Structures and spectra of VO(II)-Met-Phen complexes”.
Chou P., 1999,Photochemistry and Photobiology,vol. 70, No. 5, pp- 745-750 “Direct Spectroscopic Evidence for 1&Dgr;gO2Production from the Photolysis of Vanadium(V)-Peroxo Complexes in Adqeous Solution”.
Choukroun, R. et al., 1995,Organometallics,vol. 14, pp. 4471-4473 “Redox Properties of Cationic Vanadium (IV): [Cp2VCH3(CH3CN)][BPh4]”.
Demsar, A. et al., 1984,Journal of Fluorine Chemistry,vol. 24, No. 3, pp. 369-375 (Mar. 1984) “Synthesis and the molecular and crystal structure of aquadifluorooxo (1, 10-phenanthrolino)vanadium(IV), [VOF2(H2O) (1,10-phenanthro
D'Cruz Osmond
Ghosh Phalguni
Uckun Fatih M.
Bahar Mojdeh
Merchant & Gould P.C.
Moezie Minna
Parker Hughes Institute
LandOfFree
Vanadium (IV) metallocene complexes having spermicidal activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vanadium (IV) metallocene complexes having spermicidal activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vanadium (IV) metallocene complexes having spermicidal activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2616318